Raloxifene postmenopausal osteoporosis drug. This prescription drug acts by binding to oestrogen (estrogen) receptors, sometimes activating them and s

---

Raloxifene postmenopausal osteoporosis drug. This prescription drug acts by binding to oestrogen (estrogen) receptors, sometimes activating them and sometimes blocking them. It is classed as a selective estrogen receptor modulator (SERM). It is prescribed to treat and prevent both osteoporosis and breast cancer in postmenopausal women. Oestrogen is the primary female sex hormone. This is a generic form of the drug from the Teva pharmaceutical company.

---

Size: 5609px × 3739px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, -life, 60, background, breast, cancer, coated, cut, cut-, cut-outs, cutout, cutouts, drug, endocrinology, estrogen, female, film, generic, healthcare, hormonal, hormone, hydrochloride, life, medical, medicine, menopausal, mg, modulator, oestrogen, oral, osteoporosis, outs, packaging, packet, pharmaceutical, pharmaceutics, pharmacological, pharmacology, postmenopausal, prescription, raloxifene, receptor, selective, serm, sex, shot, studio, teva, white, women